Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL Kuti, CH Nightingale, R Quintiliani… - … and infectious disease, 2002 - Elsevier
Standard doses of piperacillin/tazobactam (9–13.5 g over 24 h) administered by continuous
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
[引用][C] Pharmacodynamic profiling of continuously infused piparacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL KUTI - Diagnostic Microbiol. & Infect. Dis., 2002 - cir.nii.ac.jp
Pharmacodynamic profiling of continuously infused piparacillin/tazobactam against
Pseudomonas aeruginosa using Monte Carlo analysis | CiNii Research CiNii 国立情報学研究所 …
Pseudomonas aeruginosa using Monte Carlo analysis | CiNii Research CiNii 国立情報学研究所 …
[引用][C] Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL KUTI, CH NIGHTINGALE… - Diagnostic …, 2002 - pascal-francis.inist.fr
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against
Pseudomonas aeruginosa using Monte Carlo analysis CNRS Inist Pascal-Francis CNRS …
Pseudomonas aeruginosa using Monte Carlo analysis CNRS Inist Pascal-Francis CNRS …
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL Kuti, CH Nightingale… - Diagnostic …, 2002 - pubmed.ncbi.nlm.nih.gov
Standard doses of piperacillin/tazobactam (9-13.5 g over 24 h) administered by continuous
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.
JL Kuti, CH Nightingale, R Quintiliani… - … and Infectious Disease, 2002 - europepmc.org
Standard doses of piperacillin/tazobactam (9-13.5 g over 24 h) administered by continuous
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL Kuti, CH Nightingale, R Quintiliani… - Diagnostic Microbiology & …, 2002 - infona.pl
Standard doses of piperacillin/tazobactam (9-13.5 g over 24 h) administered by continuous
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL Kuti, CH Nightingale, R Quintiliani… - Diagnostic Microbiology & …, 2002 - infona.pl
Standard doses of piperacillin/tazobactam (9-13.5 g over 24 h) administered by continuous
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
infusion (CI) routinely provide serum concentrations in excess of the susceptibility …
[引用][C] Pharmacodynamic profiling of continuously infused piperacillin tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
JL KUTI - Diagn. Microbiol. Infect. Dis., 2002 - cir.nii.ac.jp
Pharmacodynamic profiling of continuously infused piperacillin tazobactam against
Pseudomonas aeruginosa using Monte Carlo analysis | CiNii Research CiNii 国立情報学研究所 …
Pseudomonas aeruginosa using Monte Carlo analysis | CiNii Research CiNii 国立情報学研究所 …